Works matching IS 20564538 AND DT 2016 AND VI 2 AND IP 2


Results: 7
    1

    HR23b expression is a potential predictive biomarker for HDAC inhibitor treatment in mesenchymal tumours and is associated with response to vorinostat.

    Published in:
    Journal of Pathology: Clinical Research, 2016, v. 2, n. 2, p. 59, doi. 10.1002/cjp2.35
    By:
    • Angelika Ihle, Michaela;
    • Merkelbach-Bruse, Sabine;
    • Hartmann, Wolfgang;
    • Bauer, Sebastian;
    • Ratner, Nancy;
    • Sonobe, Hiroshi;
    • Nishio, Jun;
    • Larsson, Olle;
    • Åman, Pierre;
    • Pedeutour, Florence;
    • Taguchi, Takahiro;
    • Wardelmann, Eva;
    • Buettner, Reinhard;
    • Schildhaus, Hans-Ulrich
    Publication type:
    Article
    2
    3
    4
    5
    6
    7

    Issue Information.

    Published in:
    Journal of Pathology: Clinical Research, 2016, v. 2, n. 2, p. 57, doi. 10.1002/cjp2.46
    Publication type:
    Article